Artificial Intelligence Renal Assessment (AIRA) Version 1
Aramis Global AI Consultancies, LLC · Decision date Sep 15, 2026
What did the FDA decide?
FDA records K261677 as a 510(k) premarket notification, with a decision dated Sep 15, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 15, 2026
Regulatory record facts
- Identifier
- K261677
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Aramis Global AI Consultancies, LLC
- Product code
- QIH
- Decision code
- SESE
- Decision date
- Sep 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated Radiological Image Processing Software.
- Applicant
- Aramis Global AI Consultancies, LLC
- Product code
- QIH
- FDA device class
- 2
FDA decision timeline
K261677 received
Application receipt date recorded by FDA.
K261677 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Clever OneK260372 | Ewoosoft Co., Ltd. | 510(k) clearance | Nov 4, 2026 | FDA |
PeekMed webK262667 | Peek Health, S.A. | 510(k) clearance | Nov 4, 2026 | FDA |
CINA-Aneurysm+K262147 | AVICENNA.AI | 510(k) clearance | Oct 19, 2026 | FDA |
Ligence HeartK261733 | UAB Ligence | 510(k) clearance | Oct 7, 2026 | FDA |
NeuroDRK262134 | Deep Reasoning Ai, Inc. | 510(k) clearance | Oct 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Aramis Global AI Consultancies, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Dubai
Sources and methodology
- Original FDA record: K261677
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


